carlisle medical
Refill Requests shipment tracking contact carlisle medical
Knowledge Center
generic drug updates
Drug Patents Expiring in 2018
Released: 02/06/2018

The list below is comprised of prescription medications slated for drug patent expirations in 2018. As these dates approach, Carlisle Medical will seek opportunities to transition claimants to the generic medication versions as they become available. Please note, these are anticipated generic launch dates and are subject to change.


• Brand Name: Treximet
• Generic Name: Sumatriptan/Naproxen
• Patent Expiration Date: February 2018
• Used to treat migraines with or without aura.

• Brand Name: Sensipar
• Generic Name: Cinacalcet
• Patent Expiration Date: March 2018
• Used to treat patients with chronic kidney disease who are on dialysis. It is also used to treat high levels of calcium in the blood of patients with certain parathyroid gland problems.

• Brand Name: Spiriva
• Generic Name: Tiotropium
• Patent Expiration Date: July 2018
• Used for maintenance treatment of chronic obstructive pulmonary disease (COPD) which includes chronic bronchitis and emphysema.

• Brand Name: Tekturna
• Generic Name: Aliskiren/hctz
• Patent Expiration Date: July 2018
• Used to treat high blood pressure.

• Brand Name: Cialis
• Generic Name: Tadalafil
• Patent Expiration Date: September 2018
• Used to treat erection problems in men. It is also used for enlargement of the prostate gland in men, a condition called benign prostatic hyperplasia or BPH.

• Brand Name: Symbicort
• Generic Name: Budesonide/formoterol
• Patent Expiration Date: September 2018
• Used to treat asthma. It is also used to treat chronic obstructive pulmonary disease, including chronic bronchitis or emphysema.

• Brand Name: Levitra
• Generic Name: Vardenafil
• Patent Expiration Date: October 2018
• Used for the treatment of erectile dysfunction (ED) in men.

• Brand Name: Staxyn
• Generic Name: Vardenafil
• Patent Expiration Date: October 2018
• Used for the treatment of erectile dysfunction (ED) in men.

• Brand Name: Vesicare
• Generic Name: Solifenacin
• Patent Expiration Date: October 2018
• Used to treat overactive bladder.

• Brand Name: Fortesta
• Generic Name: Testosterone
• Patent Expiration Date: November 2018
• Used in males to treat low testosterone levels.

• Brand Name: Lyrica
• Generic Name: Pregabalin
• Patent Expiration Date: December 2018
• Used to treat nerve pain from diabetes, shingles, spinal cord injury, and fibromyalgia. It is also used to control seizures in epilepsy.

• Brand Name: Rapaflo
• Generic Name: Silodosin
• Patent Expiration Date: December 2018
• Used to treat enlargement of the prostate gland in men, a condition called benign prostatic hyperplasia or BPH.


Please contact us at 800-553-1783 or at pharmacy@carlislemedical.com if you have any questions on this announcement or if our pharmacy staff may assist you in any way.


Related Link: http://

<<Back
 
Company News
Generic Releases
Industry Related News
Industry Related Links
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2018 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer